|
US3686398A
(en)
|
1970-07-20 |
1972-08-22 |
Chevron Res |
10,9-boroxarophenanthrene as fungicides
|
|
US4194047A
(en)
|
1975-11-21 |
1980-03-18 |
Merck & Co., Inc. |
Substituted N-methylene derivatives of thienamycin
|
|
US4260543A
(en)
|
1978-07-03 |
1981-04-07 |
Merck & Co., Inc. |
Crystalline N-formimidoyl thienamycin
|
|
US4409214A
(en)
|
1979-11-19 |
1983-10-11 |
Fujisawa Pharmaceutical, Co., Ltd. |
7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
|
|
US4353807A
(en)
|
1981-03-24 |
1982-10-12 |
Mobil Oil Corporation |
Lubricants and fuels containing boroxarophenanthrene compounds
|
|
FR2573070B1
(fr)
|
1984-11-13 |
1987-01-30 |
Rhone Poulenc Sante |
Procede de preparation de composes carbonyles
|
|
US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
|
US4822786A
(en)
|
1986-07-01 |
1989-04-18 |
Kaken Pharmaceutical Co., Ltd. |
Cephalosporin compounds, and antibacterial agents
|
|
ZA893284B
(en)
|
1988-05-04 |
1990-03-28 |
Igen Inc |
Peptide analogs and their use as haptens to elicit catalytic antibodies
|
|
US5442100A
(en)
|
1992-08-14 |
1995-08-15 |
The Procter & Gamble Company |
β-aminoalkyl and β-N-peptidylaminoalkyl boronic acids
|
|
US5888998A
(en)
|
1997-04-24 |
1999-03-30 |
Synphar Laboratories, Inc. |
2-oxo-1-azetidine sulfonic acid derivatives as potent β-lactamase inhibitors
|
|
US6184363B1
(en)
|
1997-06-13 |
2001-02-06 |
Northwestern University |
Inhibitors of β-lactamases and uses therefor
|
|
US6075014A
(en)
|
1997-06-13 |
2000-06-13 |
Northwestern University |
Inhibitors of β-lactamases and uses therefor
|
|
WO2000035905A1
(en)
|
1998-12-16 |
2000-06-22 |
Northwestern University |
INHIBITORS OF β-LACTAMASES AND USES THEREFOR
|
|
AU3124300A
(en)
|
1998-12-16 |
2000-07-03 |
Northwestern University |
Inhibitors of beta-lactamases and uses therefor
|
|
EP1216239B1
(en)
|
1999-09-25 |
2004-02-11 |
SmithKline Beecham plc |
Piperazine derivatives as 5-ht1b antagonists
|
|
JP2003513890A
(ja)
|
1999-10-28 |
2003-04-15 |
メルク エンド カムパニー インコーポレーテッド |
新規なコハク酸系メタロ−β−ラクタマーゼ阻害薬およびそれの細菌感染治療での使用
|
|
WO2002022137A1
(en)
|
2000-09-12 |
2002-03-21 |
Shoichet Brian K |
β-LACTAM ANALOGS AND USES THEREFOR
|
|
JP2004509122A
(ja)
|
2000-09-14 |
2004-03-25 |
パンセリックス・リミテッド |
抗菌剤としての、３−（ヘテロアリールアセトアミド）−２−オキソ−アゼチジン−１−スルホン酸誘導体
|
|
AU2002243508A1
(en)
|
2001-01-10 |
2002-07-24 |
Bristol-Myers Squibb Company Patent Department |
Alpha-aminoboronic acids prepared by novel synthetic methods
|
|
DE10118698A1
(de)
|
2001-04-17 |
2002-11-07 |
Jerini Ag |
Verfahren zur Immobilisierung und damit hergestellte Anordnungen von Verbindungen auf einer planaren Oberfläche
|
|
WO2003057144A2
(en)
|
2001-12-26 |
2003-07-17 |
Guilford Pharmaceuticals |
Change inhibitors of dipeptidyl peptidase iv
|
|
FR2835186B1
(fr)
|
2002-01-28 |
2006-10-20 |
Aventis Pharma Sa |
Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
|
|
JP2003229277A
(ja)
|
2002-02-04 |
2003-08-15 |
Matsushita Electric Ind Co Ltd |
発光素子材料およびそれを用いた発光素子並びに装置
|
|
AUPS065102A0
(en)
|
2002-02-20 |
2002-03-14 |
Unisearch Limited |
Fluorous acetalation
|
|
KR100863667B1
(ko)
|
2002-09-11 |
2008-10-15 |
가부시끼가이샤 구레하 |
아민 화합물 및 그 용도
|
|
EP1571170B1
(en)
|
2002-10-30 |
2018-09-05 |
Sumitomo Chemical Company, Limited |
High-molecular compounds and polymer light emitting devices made by using the same
|
|
US7439253B2
(en)
|
2002-12-06 |
2008-10-21 |
Novexel |
Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
|
|
US7271186B1
(en)
|
2002-12-09 |
2007-09-18 |
Northwestern University |
Nanomolar β-lactamase inhibitors
|
|
US6936638B2
(en)
|
2002-12-20 |
2005-08-30 |
Migenix Corp. |
Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto
|
|
TW200418791A
(en)
|
2003-01-23 |
2004-10-01 |
Bristol Myers Squibb Co |
Pharmaceutical compositions for inhibiting proteasome
|
|
JP4233365B2
(ja)
|
2003-03-25 |
2009-03-04 |
三井化学株式会社 |
アザジオール錯体化合物、及び該化合物を用いる光記録媒体
|
|
WO2005033090A1
(ja)
|
2003-10-06 |
2005-04-14 |
Sumitomo Chemical Company, Limited |
芳香族化合物
|
|
MXPA06004043A
(es)
|
2003-10-10 |
2006-06-28 |
Pfizer Prod Inc |
2h-[1,2,4]triazolo[4,3-a]pirazinas sustituidas como inhibidores de la glucogeno sintetasa cinasa 3.
|
|
AU2004288831B2
(en)
|
2003-11-12 |
2010-08-26 |
Phenomix Corporation |
Heterocyclic boronic acid compounds
|
|
TW200600494A
(en)
|
2004-03-08 |
2006-01-01 |
Chugai Pharmaceutical Co Ltd |
Bisphenyl compounds useful as vitamin d3 receptor agonists
|
|
US20060019116A1
(en)
|
2004-07-22 |
2006-01-26 |
Eastman Kodak Company |
White electroluminescent device with anthracene derivative host
|
|
TW200618820A
(en)
|
2004-11-05 |
2006-06-16 |
Alza Corp |
Liposome formulations of boronic acid compounds
|
|
US20060178357A1
(en)
|
2005-02-10 |
2006-08-10 |
Buynak John D |
Chphalosporin-derived mercaptans as inhibitors of serine and metallo-beta-lactamases
|
|
ES2872962T3
(es)
|
2005-02-16 |
2021-11-03 |
Anacor Pharmaceuticals Inc |
Boronoftalidas para uso terapéutico
|
|
TWI345562B
(en)
|
2005-02-22 |
2011-07-21 |
Teva Pharma |
Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
|
|
US9184428B2
(en)
|
2005-03-15 |
2015-11-10 |
Uchicago Argonne Llc |
Non-aqueous electrolytes for lithium ion batteries
|
|
US7825139B2
(en)
|
2005-05-25 |
2010-11-02 |
Forest Laboratories Holdings Limited (BM) |
Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
TW200734311A
(en)
|
2005-11-21 |
2007-09-16 |
Astrazeneca Ab |
New compounds
|
|
KR101403164B1
(ko)
|
2005-12-07 |
2014-06-03 |
바실리어 파마슈티카 아게 |
베타-락타마아제 저해제 및 모노박탐 항생물질의 유용한조합
|
|
RU2642628C2
(ru)
|
2006-02-16 |
2018-01-25 |
Анакор Фармасьютикалз, Инк. |
Бор-содержащие малые молекулы в качестве противовоспалительных средств
|
|
WO2008039420A2
(en)
|
2006-09-27 |
2008-04-03 |
Merck & Co., Inc. |
Novel inhibitors of beta-lactamase
|
|
BRPI0809147A2
(pt)
|
2007-03-23 |
2014-08-26 |
Basilea Pharmaceutica Ag |
Medicamentos combinados para tratamento de infecções bacterianas
|
|
GB0719366D0
(en)
|
2007-10-03 |
2007-11-14 |
Smithkline Beecham Corp |
Compounds
|
|
US20100120715A1
(en)
|
2007-11-13 |
2010-05-13 |
Burns Christopher J |
Beta-lactamase inhibitors
|
|
EA201000774A1
(ru)
|
2007-11-13 |
2010-12-30 |
Новартис Интернэшнл Фармасьютикл Лтд. |
Ингибиторы бета-лактамазы
|
|
JP5038509B2
(ja)
|
2008-01-18 |
2012-10-03 |
メルク・シャープ・エンド・ドーム・コーポレイション |
β−ラクタマーゼ阻害剤
|
|
US8129398B2
(en)
|
2008-03-19 |
2012-03-06 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
|
US20100256092A1
(en)
|
2008-05-12 |
2010-10-07 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules
|
|
WO2009139834A1
(en)
|
2008-05-13 |
2009-11-19 |
Poniard Pharmaceuticals, Inc. |
Bioactive compounds for treatment of cancer and neurodegenerative diseases
|
|
US20120046242A1
(en)
|
2008-12-24 |
2012-02-23 |
Massachusetts Institute Of Technology |
Molecular activators of the wnt/beta-catenin pathway
|
|
WO2010097675A1
(en)
|
2009-02-27 |
2010-09-02 |
Dhanuka Laboratories Ltd. |
An improved preparation process for cefpodoxime proxetil
|
|
EP2406233B1
(en)
|
2009-03-09 |
2013-11-13 |
Bristol-Myers Squibb Company |
Aza pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
|
|
US20100292185A1
(en)
|
2009-05-12 |
2010-11-18 |
Burns Christopher J |
Beta-lactamase inhibitors
|
|
CA2764785C
(en)
|
2009-06-08 |
2015-10-27 |
California Capital Equity, Llc |
Triazine derivatives and their therapeutical applications
|
|
EP2458995A1
(en)
|
2009-07-28 |
2012-06-06 |
Anacor Pharmaceuticals, Inc. |
Trisubstituted boron-containing molecules
|
|
CA2828114A1
(en)
|
2010-02-26 |
2011-09-01 |
Gary Igor DMITRIENKO |
Cephalosporin derivatives useful as .beta.-lactamase inhibitors and compositions and methods of use thereof
|
|
AU2011235227B2
(en)
|
2010-03-31 |
2016-09-08 |
Millennium Pharmaceuticals, Inc. |
Derivatives of 1-amino-2-cyclopropylethylboronic acid
|
|
US20110288063A1
(en)
|
2010-05-19 |
2011-11-24 |
Naeja Pharmaceutical Inc. |
Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors
|
|
US8822516B2
(en)
|
2010-06-10 |
2014-09-02 |
Technion Research & Development Foundation Limited |
Process for the preparation of iodides
|
|
RU2599791C2
(ru)
|
2010-08-10 |
2016-10-20 |
Ремпекс Фармасьютикэлз, Инч. |
Циклические бороновые кислотно-эфирные производные и их использование в терапии
|
|
EP3034509B1
(en)
|
2010-10-26 |
2020-04-22 |
Mars, Incorporated |
Arginase inhibitors as therapeutics
|
|
AU2011329486A1
(en)
|
2010-11-18 |
2013-04-18 |
Glaxo Group Limited |
Compounds
|
|
EP2487159A1
(en)
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
|
EP2508506A1
(en)
|
2011-04-08 |
2012-10-10 |
LEK Pharmaceuticals d.d. |
Preparation of sitagliptin intermediates
|
|
CN102320960A
(zh)
|
2011-08-02 |
2012-01-18 |
安徽东健化工科技有限公司 |
一种6-氟水杨酸的制备方法
|
|
WO2013033461A1
(en)
|
2011-08-31 |
2013-03-07 |
Rempex Pharmaceuticals, Inc. |
Heterocyclic boronic acid ester derivatives and therapeutic uses thereof
|
|
WO2013053372A1
(en)
|
2011-10-13 |
2013-04-18 |
Therabor Pharmaceuticals |
Boronic acid inhibitors of beta-lactamases
|
|
WO2013056163A1
(en)
|
2011-10-14 |
2013-04-18 |
The Regents Of The University Of California |
Beta-lactamase inhibitors
|
|
SG10201605152SA
(en)
|
2011-12-22 |
2016-08-30 |
Ares Trading Sa |
Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors
|
|
WO2013104897A1
(en)
|
2012-01-09 |
2013-07-18 |
University of Tromsø |
Therapeutic boron-containing compounds
|
|
EP2615080A1
(en)
|
2012-01-12 |
2013-07-17 |
LEK Pharmaceuticals d.d. |
Preparation of Optically Pure ß-Amino Acid Type Active Pharmaceutical Ingredients and Intermediates thereof
|
|
EP2814483A2
(en)
|
2012-02-15 |
2014-12-24 |
Rempex Pharmaceuticals, Inc. |
Methods of treating bacterial infections
|
|
US9156858B2
(en)
|
2012-05-23 |
2015-10-13 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
US10561675B2
(en)
|
2012-06-06 |
2020-02-18 |
Rempex Pharmaceuticals, Inc. |
Cyclic boronic acid ester derivatives and therapeutic uses thereof
|
|
JP6403219B2
(ja)
|
2012-12-07 |
2018-10-10 |
ベナトルクス ファーマシューティカルズ，インク． |
ベータ−ラクタマーゼ阻害剤
|
|
US9101638B2
(en)
|
2013-01-04 |
2015-08-11 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
AU2014204045B2
(en)
|
2013-01-04 |
2018-10-18 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
US9241947B2
(en)
|
2013-01-04 |
2016-01-26 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
KR20150103270A
(ko)
|
2013-01-04 |
2015-09-09 |
렘펙스 파머수티클스 인코퍼레이티드 |
보론산 유도체 및 그의 치료적 용도
|
|
CN105101970B
(zh)
|
2013-01-10 |
2018-11-20 |
维纳拓尔斯制药公司 |
β-内酰胺酶抑制剂
|
|
WO2014151958A1
(en)
|
2013-03-14 |
2014-09-25 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
ES2683329T3
(es)
|
2013-03-15 |
2018-09-26 |
Intrexon Corporation |
Diacilhidrazinas que contienen boro
|
|
WO2015171398A1
(en)
|
2014-05-05 |
2015-11-12 |
Rempex Pharmaceuticals, Inc. |
Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof
|
|
US10385074B2
(en)
|
2014-05-05 |
2019-08-20 |
Rempex Pharmaceuticals, Inc. |
Synthesis of boronate salts and uses thereof
|
|
AU2015264418A1
(en)
|
2014-05-19 |
2016-11-10 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
US9511142B2
(en)
|
2014-06-11 |
2016-12-06 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
KR102396753B1
(ko)
|
2014-06-11 |
2022-05-12 |
베나토알엑스 파마슈티컬스, 인크. |
베타-락타마제 억제제
|
|
AU2015284307A1
(en)
|
2014-07-01 |
2017-02-02 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
WO2016065282A1
(en)
|
2014-10-24 |
2016-04-28 |
The Regents Of The University Of Michigan |
Nasal formulation, nasal kit, and method for enhancing nasal nitric oxide (no) levels
|
|
WO2016081297A1
(en)
|
2014-11-18 |
2016-05-26 |
Rempex Pharmaceuticals, Inc. |
Cyclic boronic acid ester derivatives and therapeutic uses thereof
|
|
US20170252351A1
(en)
|
2015-01-24 |
2017-09-07 |
Wockhardt Limited |
Antibacterial Compositions
|
|
WO2016149393A1
(en)
*
|
2015-03-17 |
2016-09-22 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
WO2016172208A1
(en)
|
2015-04-24 |
2016-10-27 |
Rempex Pharmaceuticals, Inc. |
Methods of treating bacterial infections
|
|
WO2017100537A1
(en)
|
2015-12-10 |
2017-06-15 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
AU2017290060B2
(en)
*
|
2016-06-30 |
2021-07-22 |
Qpex Biopharma, Inc |
Boronic acid derivatives and therapeutic uses thereof
|
|
AU2017295866A1
(en)
|
2016-07-14 |
2019-01-17 |
Achaogen, Inc. |
Combination of ceftibuten and clavulanic acid for use in the treatment of bacterial infections
|
|
SG11201901658PA
(en)
|
2016-09-16 |
2019-04-29 |
Entasis Therapeutics Ltd |
Beta-lactamase inhibitor compounds
|
|
US10085999B1
(en)
|
2017-05-10 |
2018-10-02 |
Arixa Pharmaceuticals, Inc. |
Beta-lactamase inhibitors and uses thereof
|
|
BR112020007138B1
(pt)
|
2017-10-11 |
2023-03-21 |
Qpex Biopharma, Inc |
Derivados de ácido borônico, métodos de síntese, composição farmacêutica e uso dos mesmos
|
|
WO2019093450A1
(ja)
|
2017-11-10 |
2019-05-16 |
塩野義製薬株式会社 |
ジアザビシクロオクタン誘導体
|
|
CN112424209A
(zh)
|
2018-04-20 |
2021-02-26 |
Qpex生物制药有限公司 |
硼酸衍生物及其治疗用途
|
|
DK3886798T3
(da)
|
2018-11-29 |
2026-04-20 |
Basilea Pharmaceutica Int Ag Allschwil |
Kombinationssammensætninger, som omfatter en beta-lactamase-hæmmer, og anvendelser deraf
|
|
US12636297B2
(en)
|
2019-06-19 |
2026-05-26 |
Qpex Biopharma, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
EP4021443A1
(en)
|
2019-08-29 |
2022-07-06 |
Arixa Pharmaceuticals, Inc. |
Orally administered combinations of beta-lactam antibiotics and avibactam derivatives for treating bacterial infections
|